TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

ADENOSINE

ADENOSINE
Approved 2004-06-16
Jump to: Indications Approvals Trials Competitors Safety Patents
18
Indications
--
Phase 3 Trials
21
Years on Market

Details

Status
Discontinued
First Approved
2004-06-16
Routes
INJECTION, INTRAVENOUS
Dosage Forms
INJECTABLE, SOLUTION

Companies

Hikma Fresenius Kabi EUGIA PHARMA MEITHEAL WOCKHARDT Pfizer Viatris GLAND PHARMA LTD RISING AM REGENT AVET LIFESCIENCES BEDFORD LABS GLAND Teva PHARMOBEDIENT
Active Ingredient: ADENOSINE

ADENOSINE Approval History

Loading approval history...

What ADENOSINE Treats

18 FDA approvals

Originally approved for its first indication in 2004 . Covers 18 distinct patient populations.

  • Other (18)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ADENOSINE FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: ANDA076501 → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.